Treatment of primary central nervous system lymphoma with a combination of intraventricular administration of rituximab and systemic chemotherapy.

被引：0
|
作者：
Wang, Shujie
Zhang, Wei
Lian, Wei
Wu, Yongji
Zou, Nong
Zhu, Tienan
Zhou, Daobin
Xu, Ying
Shen, Ti
Zhao, Yongqiang
机构：
[1] Beijing Union Med Coll Hosp, Dept Hematol, Beijing, Peoples R China
[2] Beijing Union Med Coll Hosp, Dept Neurosurg, Beijing, Peoples R China
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4695
引用
收藏
页码：256B / 256B
页数：1
相关论文
共 50 条
  • [1] Treatment of central nervous system lymphoma in rats with intraventricular rituximab and serum
    Yasuyuki Miyake
    Yasushi Okoshi
    Takayuki Machino
    Shigeru Chiba
    [J]. International Journal of Hematology, 2010, 92 : 474 - 480
  • [2] Treatment of central nervous system lymphoma in rats with intraventricular rituximab and serum
    Miyake, Yasuyuki
    Okoshi, Yasushi
    Machino, Takayuki
    Chiba, Shigeru
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 92 (03) : 474 - 480
  • [3] Intraventricular primary central nervous system lymphoma
    Guedes, LC
    Barroso, C
    Ruivo, N
    Pimentel, JG
    [J]. JOURNAL OF NEUROLOGY, 2005, 252 : 68 - 68
  • [4] The Role of Rituximab in the Treatment of Primary Central Nervous System Lymphoma
    Van Dijck, Ruben
    Doorduijn, Jeanette K.
    Bromberg, Jacoline E. C.
    [J]. CANCERS, 2021, 13 (08)
  • [5] Intrathecal administration of rituximab for the treatment of primary central nervous system B-cell lymphoma
    Fernandes, FB
    Silla, L
    Friedrisch, JR
    Brusius, C
    [J]. BLOOD, 2005, 106 (11) : 281B - 281B
  • [6] LONG-TERM SURVIVORS OF A SYSTEMIC AND INTRAVENTRICULAR CHEMOTHERAPY WITH DEFERRED RADIOTHERAPY IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
    Juergens, A.
    Pels, H.
    Rogowski, S.
    Schulz, H.
    Reichmann, H.
    Vogt-Schaden, M.
    Schmidt-Wolf, I. G. H.
    Schlegel, U.
    [J]. NEURO-ONCOLOGY, 2008, 10 (06) : 1085 - 1085
  • [7] Intraventricular treatment of relapsed and refractory central nervous system (CNS) lymphoma with rituximab.
    Schulz, H
    Pels, H
    Hom, E
    Thall, A
    Engert, A
    [J]. BLOOD, 2001, 98 (11) : 249B - 249B
  • [8] Treatment of primary central nervous system lymphoma with induction of complement-dependent cytotoxicity by intraventricular administration of autologous-serum-supplemented rituximab
    Takami, A
    Hayashi, T
    Kita, D
    Nishimura, R
    Asakura, H
    Nakao, S
    [J]. CANCER SCIENCE, 2006, 97 (01) : 80 - 83
  • [9] Combination chemotherapy and radiation therapy for primary central nervous system lymphoma
    Schneider, AG
    Shapiro, WR
    Isaacs, J
    [J]. NEUROLOGY, 1996, 46 (02) : 66003 - 66003
  • [10] Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma
    Sun, Xuefei
    Liu, Jing
    Wang, Yaming
    Bai, Xueyan
    Chen, Yuedan
    Qian, Jun
    Zhu, Hong
    Liu, Fusheng
    Qiu, Xiaoguang
    Sun, Shengjun
    Ji, Nan
    Liu, Yuanbo
    [J]. ONCOTARGET, 2017, 8 (30) : 49156 - 49164
12345